C. Wielders

Notification data and criteria during a large Q-fever epidemic reassessed

W. van der Hoek, F. Dijkstra, P. Schneeberger, 2019, Epidemiology and Infection.

Antibiotic Resistance and the Risk of Recurrent Bacteremia

C. Visser, M. Bonten, A. Buiting, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease

W. van der Hoek, W. Paget, J. van der Velden, 2015, Epidemiology and Infection.

Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study

A. Troelstra, E. Kuijper, A. Buiting, 2022, Annals of Clinical Microbiology and Antimicrobials.

Coxiella burnetii Prohibit IgG Antibody Responses to with Symptomatic Acute Q Fever Do Not Early Diagnosis and Treatment of Patients

P. Wever, A. Hoepelman, P. Schneeberger, 2012 .

Indicative of Chronic Q Fever Progression to a Serologic Profile during Acute Q Fever Is Associated with High Coxiella burnetii DNA Load in Serum

M., N. Renders, P. Wever, 2013 .

Single nucleotide polymorphisms in immune response genes in acute Q fever cases with differences in self-reported symptoms

R. Janssen, Y. V. van Duynhoven, C. Hoebe, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Use of a Dose–Response Model to Study Temporal Trends in Spatial Exposure to Coxiella burnetii: Analysis of a Multiyear Outbreak of Q Fever

L. Waller, M. Kretzschmar, P. Teunis, 2017, Zoonoses and public health.

Correlations between Peripheral Blood Coxiella burnetii DNA Load, Interleukin-6 Levels, and C-Reactive Protein Levels in Patients with Acute Q Fever

R. Janssen, P. Wever, H. Hodemaekers, 2014, Clinical and Vaccine Immunology.